EV/EBITDA:
-1.65-0.13(-8.55%)Summary
- As of today, MLTX EV/EBITDA is -1.65, with a fall of -0.13 (-8.55%) during the most recent trading session on October 13, 2025.
- Over the past year, MLTX EV/EBITDA has increased by +22.28 (+93.10%).
- MLTX EV/EBITDA is now -587.50% below its all-time high of -0.24.
Performance
MLTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -8.6% | +8.4% | +3.9% |
| 1M1 Month | +89.1% | -89.0% | -79.7% |
| 3M3 Months | +88.1% | -88.1% | -78.2% |
| 6M6 Months | +84.6% | -81.9% | -69.5% |
| YTDYTD | +92.1% | -89.0% | -80.3% |
| 1Y1 Year | +93.1% | -87.4% | -78.2% |
| 5Y5 Years | - | - | - |
MLTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -0.24 | -587.5% | -18.08 | +90.9% |
| 3M | 3-Month | -0.24 | -587.5% | -18.08 | +90.9% |
| 6M | 6-Month | -0.24 | -587.5% | -18.08 | +90.9% |
| 1Y | 1-Year | -0.24 | -587.5% | -28.21 | +94.2% |
| 3Y | 3-Year | -0.24 | -587.5% | -61.99 | +97.3% |
| 5Y | 5-Year | -0.24 | -587.5% | -1492 | +99.9% |
| All-Time | All-Time | -0.24 | -587.5% | -1492 | +99.9% |
MLTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.65(+92.1%) |
| 2024 | -20.96(+63.9%) |
| 2023 | -58.11(-1019.7%) |
| Date | Value |
|---|---|
| 2022 | -5.19(-121.8%) |
| 2021 | -2.34(+99.8%) |
| 2020 | -1333.00 |
FAQ
- What is MoonLake Immunotherapeutics EV/EBITDA?
- What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?
- What is MLTX EV/EBITDA year-to-date change?
- What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
What is MoonLake Immunotherapeutics EV/EBITDA?
The current EV/EBITDA of MLTX is -1.65
What is the all-time high EV/EBITDA for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high EV/EBITDA is -0.24
What is MLTX EV/EBITDA year-to-date change?
MoonLake Immunotherapeutics EV/EBITDA has changed by +19.31 (+92.13%) since the beginning of the year
What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
Over the past year, MLTX EV/EBITDA has changed by +22.28 (+93.10%)